pharmaceuticals, it had a massive baby-food division, a worldwide chain of fertility clinics and a group of prestigious private hospitals. Bendix Schere had been one of the first pharmaceutical companies to invest heavily in genetics research and was the largest single provider of research funds for genetics in the country.
For the past thirty years Dick Bannerman had refused to go to the pharmaceutical industry for funding, because he was passionately against the whole concept of patenting. Knowledge should be shared, he believed, and it was a principle he rigidly adhered to at Bannerman Genetics Research sited on the campus of Berkshire University. His funding came partly from the university, partly â and very sporadically â from the government, and even more sporadically from a handful of charitable organizations â in particular those supporting research into genetic-linked diseases, such as the Imperial Cancer Research Foundation, the Cystic Fibrosis Trust, and the Parkinsonâs Foundation.
But with the constant expense of keeping up to date in technology, combined with the increasing desire of funders to see a return on their investment beyond pure research results, the pressure in keeping the labs running, with their staff oftwenty, was taking its toll. Whenever Monty thought about the breakthroughs her father had made despite all the handicaps, she wondered how much more he could achieve with better funding. Sir Neil Rorke might just be the answer. âIâve never heard anything good about Bendix Schere,â Dick Bannerman said.
âWhat have you heard thatâs bad?â
He pushed a toothpick into the side of his mouth and bit on it. âNothing specific. Theyâre obsessively secretive.â
âSoâs the whole pharmaceutical industry.â
âRorkeâs not going to offer any funding without wanting his pound of flesh.â
âPatents arenât that terrible, Daddy â and they donât last for ever. Seventeen years in the UK â thatâs not long.â
He looked at her with his head slanted. âSeventeen years will see me out.â
âI hope not.â
âWell â youâll be pushing me round in a wheelchair, and Iâll be gaga.â
âAnd still scratching around for funding.â
The remark silenced him, and she knew the barb had struck home.
He was getting tired of the fight for money; and he knew that time was running out on him. Theyâd had a letter from Berkshire University telling them, with regret, that their funding was going to be halved for the next three years; it had added that with Dr Bannermanâs recent achievements in genetics there should be little difficulty finding funding from the commercial sector. The government had been making similar hints. He was going to have to go cap in hand to the pharmaceutical industry one day, and right now he was riding high. The timing had never been better.
âYou have nothing to lose by meeting Sir Neil,â Monty said. âIf you donât like what he says, then fine.â
âYup, OK, fine, weâll meet, see whatâs what. Will you come too â help assess him? Maybe you can charm some loot out of him.â
âSure Iâll come. Whenever Iâve seen him on television he always looks very friendly.â
Dick Bannerman removed the toothpick and twisted it in his fingers, examining the tip. âCobras always smile before they strike.â
4
Berkshire
,
England.
October
,
1993
On Tuesday nights Anna Sterlingâs husband Mark went to rugger practice, followed by a drinking session then a curry with the guys. Monty Bannerman and Anna usually had supper together or went to a film.
They had been meeting up like that, weekly, for as long as Monty could remember. Anna was her oldest friend, and she was also one of her few remaining pals who did not have children. Monty was aware that was probably the main reason